| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |